Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

A major research project to advance regenerative therapy for epidermolysis bullosa (EB) using transgenic stem cells

Shriners Children's announces new cutting-edge gene and stem cell therapy research program to be supported by the Howard Green Center for Children's Skin Health & Research at Shriners Hospitals for Children -- Boston.


News provided by

Shriners Hospitals for Children

Nov 01, 2021, 15:45 ET

Share this article

Share toX

Share this article

Share toX


BOSTON, Nov. 1, 2021 /PRNewswire-PRWeb/ -- Shriners Children's is pleased to announce that a cutting-edge gene and stem cell therapy research program to cure the rare skin blistering disorder is to be supported by the Howard Green Center for Children's Skin Health & Research at Shriners Hospitals for Children — Boston.

The lead scientist is Dr. Jeffrey Morgan who has proven track record of successful innovation and leadership skills. Dr. Morgan will guide this program as it pursues its goal of improving the outcomes and lives of patients with burns, skin disorders and dermatological conditions. The expert co-investigators on the research project are Robert Sheridan M.D., Mehmet Toner Ph.D., and Martin Yarmush M.D., Ph.D., all at Massachusetts General Hospital (MGH), Harvard Medical School (HMS) and Shriners Children's Boston.

“Dr. Green dedicated his career to furthering our understanding of skin regeneration and improving the outcomes for patients,” Dr. Morgan said. “I am honored not only to build on his work in helping improve the lives of patients, but to do so together with Shriners Hospitals for Children.”

Post this

Dr. Morgan has extensive experience in genetically engineering skin to treat various genetic disorders or to deliver local wound healing factors. His interdisciplinary research has produced 110 publications in high-impact, peer-reviewed scientific journals. Working in translation and commercialization of technologies, Dr. Morgan is an inventor on thirteen issued patents and was elected a Fellow of the National Academy of Inventors. Innovations developed in his laboratories are distributed worldwide. Dr. Morgan has served in a number of leadership positions in academia as well as start-up companies.

Dr. Morgan trained at Massachusetts Institute of technology with Howard Green, M.D. Dr. Green was the first to grow skin grafts using a patient's own cells, one of the earliest examples of stem cell therapy. The first grafts from cultured skin were used to treat two patients with life threatening burns at Shriners Hospitals for Children — Boston in the early 1980s, cementing the impact of Dr. Green's discovery as well as his bond with Shriners Hospitals for Children.

"Dr. Green dedicated his career to furthering our understanding of skin regeneration and improving the outcomes for patients," Dr. Morgan said. "I am honored not only to build on his work in helping improve the lives of patients, but to do so together with Shriners Hospitals for Children."

"Dr. Morgan's appointment as principal investigator will help the Howard Green Center for Children's Skin Health & Research take the next step in caring for patients with devastating skin injuries and conditions," said Jerry G. Gantt, Chairman of the Board of Trustees of Shriners Hospitals for Children. "Dr. Morgan's leadership in the field and longtime connection with Dr. Howard Green make him a natural choice to lead the research project, and we are honored to have him as an important part of our Shriners Children's family."

About the Howard Green Center for Children's Skin Health & Research at Shriners Children's Boston
Founded in 2016, the Howard Green Center for Children's Skin Health and Research at Shriners Hospitals for Children — Boston is a first-of-its kind center dedicated to advancing the field of regenerative medicine. The mission is to engage in translational research projects that work hand-in-hand with clinical practice to move regenerative medicine along the discovery continuum to bring new treatments to children more quickly. The ultimate goal is to further improve the outcomes and lives of patients with burns, skin disorders and dermatological conditions by providing world-class care regardless of the families' ability to pay.

The Center is the vision of Dr. Green and his family. By making a generous and transformational gift to Shriners Hospitals for Children — Boston, Mrs. Rosine Kauffmann Green ensured her late husband's work would continue on and help children in Boston and around the world.

About Shriners Children's
Shriners Children's is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our health care system provides care for children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care and services are provided regardless of the families' ability to pay. Since opening its first location in 1922, the health care system has treated more than 1.5 million children. To learn more, please visit shrinershospitalsforchildren.org.
Media Contact:
Mel Bower, Shriners Hospitals for Children
813-281-8643, [email protected]

Media Contact

Ashley Ozols, Shriners Hospitals for Children, +1 8133672826, [email protected]

SOURCE Shriners Hospitals for Children

Related Links

http://shrinershospitalsforchildren.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.